FRANKFURT, Nov 3 (Reuters) - Germany's BioNTech (22UAy.DE), opens new tab on Monday lifted its 2025 revenue guidance after receiving initial payments from its new partner Bristol Myers Squibb (BMY.N), ...

** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** If you aren’t familiar, CZ stands ...

The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. Pushing deeper into in vivo cell therapies, BMS has agreed to pay $1.5 billion to buy the biotech for a pipeline led by a ...

On the heels of the launch of an online direct-to-patient (DTP) program offering discounted Eliquis to certain U.S. patients, Bristol Myers Squibb is putting Sotyku at the center of its next DTP ...

More than 40 years after establishing the first U.S. pharmaceutical joint venture in China, Bristol Myers Squibb is handing over its controlling stake in the business. BMS has inked an agreement to ...

President Trump signed the $900 billion coronavirus relief package on Sunday. A new round of financial relief has finally been green-lit by the government and should flow to millions of Americans ...

Bristol Myers Squibb (BMS) has agreed to co-develop and co-commercialize BioNTech’s cancer-fighting bispecific antibody candidate BNT327 across numerous solid tumor types through a collaboration that ...

One of Pennsylvania's premier outdoor recreation destinations is open for the season.The Northcentral Regional ATV Trail – which offers more than 600 miles of connected trails across Clinton, Lycoming ...

The Coca-Cola 600 marks the 129th Cup race hosted by Charlotte Motor Speedway in the series’ history. The 1.5-mile oval located in Concord, North Carolina has an asphalt racing surface with 24 degrees ...

The 2025 Coca-Cola 600 is back at Charlotte Motor Speedway for another year of racing. A 600-mile race that requires 400 laps to complete, it will mark the next race of the 2025 NASCAR Cup Series ...

Bristol Myers Squibb, Board Chair of BMS and CEO Christopher Boerner, PhD, have committed the pharma giant to investing $40 billion over the next five years toward U.S. research and development (R&D), ...

Princeton-based pharma Bristol Myers Squibb is planning another round of layoffs in New Jersey as part of a broader restructuring plan. In a filing with the state Department of Labor & Workforce ...